Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.079 | 0.7 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |